1-4 of 4
Eduardo Yanez Ruiz
Close
Sort by
Journal Articles

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

Clinical Trials & Observations
Meletios Dimopoulos, Sara Bringhen, Pekka Anttila, Marcelo Capra, Michele Cavo, Craig Cole, Cristina Gasparetto, Vania Hungria, Matthew Jenner, Vladimir Vorobyev, Eduardo Yanez Ruiz, Jian Y. Yin, Rao Saleem, Maeva Hellet, Sandrine Macé, Bruno Paiva, Ravi Vij
Journal: Blood
Blood (2021) 137 (9): 1154–1165.
https://doi.org/10.1182/blood.2020008209
Published: 2021
Includes: Supplemental data
Journal Articles

Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Larry W Kwak, MD PhD, Juan Manuel Sancho, MD PhD, Seok-Goo Cho, MD, PhD, Hideyuki Nakazawa, MD PhD, Junji Suzumiya, MD PhD, Gayane Tumyan, Jin Seok Kim, MD PhD, Tobias F Menne, MD PhD FRCPath, Jose Mario Mariz, Nikolai Ilyin, DMSc, MD PhD, Wojciech Jurczak, MD PhD, Aurelio Lopez Martínez, MD, Olga Samoilova, MD, Edvard Zhavrid, MD PhD, Eduardo Yanez Ruiz, MD, Marek Trneny, MD prof, Leslie L. Popplewell, MD FRCPA, Michinori Ogura, MDPhD, Won Seog Kim, MD PhD, Sang Joon Lee, PhD, Sung Hyun Kim, PhD, Keum Young Ahn, PhD, Christian Buske, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-135999
Published: 2020
Journal Articles

Results from a Phase II Study of Isatuximab As a Single Agent and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Meletios A Dimopoulos, MD, Sara Bringhen, MD, Pekka Anttila, MD, Marcelo Capra, MD PhD, Michele Cavo, MD, Craig E. Cole, MD, Cristina J Gasparetto, MD, Vania T. M. Hungria, MD PhD, Matthew Jenner, Vladimir Vorobyev, MD PhD, Eduardo Yanez Ruiz, Jianyun Yin, Anthony Hamlett, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 155.
https://doi.org/10.1182/blood-2018-155
Published: 2018
Journal Articles

Comparison of Efficacy and Safety of Biosimilar CT-P10 to Rituximab in Patients with Previously Untreated Low Tumor Burden Follicular Lymphoma (LTBFL): A Randomized Phase III Study

Michinori Ogura, MDPhD, Juan Manuel Sancho, MD PhD, Seok-Goo Cho, MD PhD, Hideyuki Nakazawa, PhD MD, Junji Suzumiya, MD PhD, Gayane Tumyan, DMSc, MD PhD, Jin Seok Kim, MD PhD, Anne Lennard, MBBS,FRCP, FRCPath, Jose Mario Mariz, MD, Nikolai Ilyin, DMSc, MD PhD, Wojciech Jurczak, MDPhD, Aurelio Lopez Martinez, MD, Olga Samoilova, MD, Edvard Zhavrid, MD PhD, Eduardo Yanez Ruiz, MD, Marek Trneny, MD CSc, Leslie Popplewell, MD, Bertrand Coiffier, MD PhD, Christian Buske, MD, Won Seog Kim, MD PhD, SangJoon Lee, PhD, Sungyoung Lee, YunJu Bae, Larry W Kwak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1596.
https://doi.org/10.1182/blood-2018-99-110334
Published: 2018